| 臺大學術典藏 |
2019-09-16T09:25:32Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO;Liu, Tu Chen;Hsia, Te Chun;Lin, Ching Hsiung;Chang, Chih Cheng;Wei, Yu Feng;Wu, Ming Fang;Chian, Chih Feng;Lin, Chia Mo;Shieh, Jiunn Min;Huang, Wen Tsung; Huang, Wen Tsung; Shieh, Jiunn Min; Lin, Chia Mo; Chian, Chih Feng; Wu, Ming Fang; Wei, Yu Feng; Chang, Chih Cheng; Lin, Ching Hsiung; Hsia, Te Chun; Liu, Tu Chen; JEN-CHUNG KO |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO; Wei, Yu-Feng; Huang, Wen-Tsung; Liu, Tu-Chen; Shieh, Jiunn-Min; Chian, Chih-Feng; Wu, Ming-Fang; Chang, Chih-Cheng; Lin, Ching-Hsiung; Lin, Chia-Mo; Hsia, Te-Chun |
| 臺大學術典藏 |
2021-10-04T07:15:40Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C. |
| 臺大學術典藏 |
2021-03-11T07:58:28Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C. |
| 臺大學術典藏 |
2021-03-11T08:29:33Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C. |
| 臺大學術典藏 |
2021-03-11T08:34:19Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C. |
| 國立臺灣大學 |
2005 |
Factors Associated with Increased Plasma Homocysteine in Patients Using an Amino Acid Peritoneal Dialysis Fluid
|
楊紹佑; 黃政文; 施凱耀; 徐世平; 朱培倫; 朱宗信; 吳寬墩; YANG, SHAO-YU; HUANG, JENQ-WEN; SHIH, KAI-YAO; HSU, SHIH-PING; CHU, PEI-LUN; CHU, TZONG-SHINN; WU, KWAN-DUN |
| 臺大學術典藏 |
2005 |
Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid
|
Shao-Yu Yang;Huang J.-W.;Shih K.-Y.;Hsu S.-P.;Chu P.-L.;Chu T.-S.;Wu K.-D.; SHAO-YU YANG; Huang J.-W.; Shih K.-Y.; Hsu S.-P.; Chu P.-L.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2005 |
Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid
|
Wu K.-D.; Chu T.-S.; Chu P.-L.; Hsu S.-P.; Shih K.-Y.; JENQ-WEN HUANG; Yang S.-Y.; Yang S.-Y.;Jenq-Wen Huang;Shih K.-Y.;Hsu S.-P.;Chu P.-L.;Chu T.-S.;Wu K.-D. |
| 臺大學術典藏 |
2021-07-20T03:15:50Z |
Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid
|
Yang S.-Y.; Huang J.-W.; Shih K.-Y.; Hsu S.-P.; Chu P.-L.; TZONG-SHINN CHU; Wu K.-D. |
